Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serologic abnormalities in systemic sclerosis.

G R Harvey1, N J McHugh

  • 1School of Postgraduate Medicine, University of Bath, UK. mpsgrh@bath.ac.uk

Current Opinion in Rheumatology
|November 7, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features.

Neuropathology and applied neurobiology·2018
Same author

Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis.

Neuropathology and applied neurobiology·2018
Same author

Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.

Annals of the rheumatic diseases·2017
Same author

Microparticle subpopulations are potential markers of disease progression and vascular dysfunction across a spectrum of connective tissue disease.

BBA clinical·2017
Same author

Symptoms of Raynaud's phenomenon (RP) in fibromyalgia syndrome are similar to those reported in primary RP despite differences in objective assessment of digital microvascular function and morphology.

Rheumatology international·2016
Same author

Association of Toll-like receptor 4 (TLR4) with chronic plaque type psoriasis and psoriatic arthritis.

Archives of dermatological research·2016
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Systemic sclerosis (SSc) patients often have specific autoantibodies, each linked to distinct disease subtypes and clinical features. These autoantibodies act as indicators of underlying disease processes, aiding in understanding SSc subtypes.

Area of Science:

  • Immunology
  • Rheumatology
  • Genetics

Background:

  • Most systemic sclerosis (SSc) patients possess one of three mutually exclusive autoantibodies.
  • These autoantibodies correlate with specific clinical manifestations and human lymphocyte antigen (HLA) alleles.

Purpose of the Study:

  • To propose a model for understanding the distinct pathogenic pathways in systemic sclerosis (SSc).
  • To explore the role of SSc-associated autoantibodies as indicators of disease subtypes and their etiopathogenesis.

Main Methods:

  • Review and synthesis of existing evidence on SSc-associated autoantibodies.
  • Analysis of correlations between autoantibody profiles, clinical features, and HLA alleles.

Main Results:

Related Experiment Videos

  • Identification of three distinct disease processes in SSc, each associated with specific autoantibodies (anti-RNA polymerase III, anti-topoisomerase I, anti-centromere antibodies).
  • Evidence suggests HLA-restricted presentation of cryptic epitopes leads to autoantibody production.
  • SSc autoantibodies serve as reliable markers for distinct pathological phenomena.

    • Conclusions:

    • Systemic sclerosis likely comprises three distinct disease entities.
    • SSc-associated autoantibodies are valuable indicators of specific pathological processes and may guide etiopathogenesis research.
    • Understanding these subtypes can improve diagnosis and treatment strategies for SSc.